Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 13, 1996

View Archived Issues

Therapeutically active cysteine proteinase inhibitors described by Synphar

Roussel Uclaf reports new quinoline derivatives

NK1 antagonists described by Boehringer Ingelheim

Novel 5-HT4 receptor agonist claimed by Pharmacia & Upjohn

Abbott reports on new PAF antagonists

Chugai reports new cholesterol-lowering compounds

New immunostimulant from Snow Brand

Antihypertensive peptides disclosed by Snow Brand

Novel mechanism of action reported for Xenova PAI inhibitor

Myriad Genetics announces research collaboration

Encouraging clinical results with MacroChem Rx for impotence

BioDelivery Sciences and Wyeth-Lederle Vaccines collaboration

Atlantic Pharmaceuticals issued U.S. patent

Positive phase IIa results for therapeutic vaccine for genital warts

PLC Systems allowed to expand Heart Laser trials

ADAC's Molecular Coincidence Detection shows promising results

Visible Genetics acquires BIOS Laboratories technology

RSV MAb from MedImmune enters pivotal trials

Biomira strengthens patent rights to Mucin 1 cancer antigen

5-LO inhibitor approved by FDA

NDA filed for Antizol

Taxotere now approved in 44 countries

Glaxo Wellcome evaluates new alpha1a-adrenoceptor antagonist

BioProCon to market DiagnoCure bladder cancer diagnostic

New HIV-1 protease inhibitor in development at LG Chemical

New ET antagonist in preclinical testing at Parke-Davis

Vertex selects lead development candidate for autoimmune diseases

Ivax generic cardiovascular drug approved in U.S.

DuPont Merck reports pharmacokinetic data for novel gpIIb/IIIa antagonist

Faulding receives approval for generic contrast media

DuPont Merck evaluates new candidate cognition enhancer

Oral butyrate prodrug in preclinical testing at Vertex

Advisory committee recommends approval of non-nicotine smoking cessation product

First marketing approval for Allergan antipsoriatic

BMS in-licenses antifungal triazole from Eisai

FDA panel recommends approval of BeneFix

Nortran's antiarrhythmic agents receive patent protection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...